The microbiota-gut-brain axis is a complex network that includes the enteric nervous system (ENS), the autonomic nervous system (ANS), and the neuroendocrine and neuroimmunity of the central nervous system (CNS). The microbiota-gut-brain axis can send signals through a multitude of channels. These processes have a variety of effects on physiological function. The gut-liver axis refers to the gastrointestinal tract and liver's intimate anatomical and functional link. The transfer of IM-associated molecules to the liver occurs during the interaction between the two organs, whether healthy or sick. The microbiota-gut-liver-brain axis controls the onset and progression of many diseases, and it provides a new avenue for disease study. There have been an increasing number of studies on the microbiota-gut-liver-brain axis in recent years, which has not only improved our understanding of its pathogenesis but also provided numerous new therapy options.
Title : Probiotics in the prevention and treatment of atherosclerotic cardiovascular disease: Focus on molecular mechanisms
Dipak P Ramji, Cardiff University, United Kingdom
Title : Phytochemical analysis and antioxidant activity of Physalis minima
Suriyavathana Muthukrishnan, Periyar University, India
Title : Scale up for manufacturing Next Generation Probiotics: Process development strategies and processes to fast track products into the market
Jason Ryan, Sacco System, Australia
Title : Effect of dietary probiotic on the pH and colour characteristics of carcasses, breast fillets and drumsticks of broilers
Nurinisa Esenbuga, Ataturk University, Turkey
Title : Canned cherries made with lactitol or xilitol: A dietetics and prebiotic alternative to reduce its caloric value
Mariela Maldonado, CONICET-UTN FRM, Argentina
Title : Probiotics strains of Bifidobacterium bifidum and Lactobacillus for cholesterol removal is related to bile salt hydrolase activity
Shoukat Parvez, The University of Faisalabad, Pakistan